MX2010003112A - Formas de dosificacion solubles que contienen derivados de cephem adecuados para administracion parenteral. - Google Patents

Formas de dosificacion solubles que contienen derivados de cephem adecuados para administracion parenteral.

Info

Publication number
MX2010003112A
MX2010003112A MX2010003112A MX2010003112A MX2010003112A MX 2010003112 A MX2010003112 A MX 2010003112A MX 2010003112 A MX2010003112 A MX 2010003112A MX 2010003112 A MX2010003112 A MX 2010003112A MX 2010003112 A MX2010003112 A MX 2010003112A
Authority
MX
Mexico
Prior art keywords
dosage forms
parenteral administration
forms containing
derivatives suitable
cephem derivatives
Prior art date
Application number
MX2010003112A
Other languages
English (en)
Spanish (es)
Inventor
Mahendra Dedhiya
Yigong Ge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40468354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010003112(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2010003112A publication Critical patent/MX2010003112A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
MX2010003112A 2007-09-21 2008-09-19 Formas de dosificacion solubles que contienen derivados de cephem adecuados para administracion parenteral. MX2010003112A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97419407P 2007-09-21 2007-09-21
PCT/US2008/076920 WO2009039324A1 (en) 2007-09-21 2008-09-19 Soluble dosage forms containing cephem derivatives suitable for parenteral administration

Publications (1)

Publication Number Publication Date
MX2010003112A true MX2010003112A (es) 2010-08-11

Family

ID=40468354

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003112A MX2010003112A (es) 2007-09-21 2008-09-19 Formas de dosificacion solubles que contienen derivados de cephem adecuados para administracion parenteral.

Country Status (11)

Country Link
US (3) US20090082326A1 (enExample)
EP (2) EP2200618A4 (enExample)
JP (1) JP2010540448A (enExample)
KR (1) KR101599560B1 (enExample)
CN (3) CN101868240A (enExample)
AU (1) AU2008302201A1 (enExample)
BR (1) BRPI0816412A2 (enExample)
CA (1) CA2700263A1 (enExample)
MX (1) MX2010003112A (enExample)
RU (1) RU2537237C2 (enExample)
WO (1) WO2009039324A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2012003201A (es) * 2009-09-21 2012-05-08 Astrazeneca Ab Composiciones y metodos para tratar infecciones bacterianas utilizando ceftarolina.
TWI679977B (zh) * 2011-10-19 2019-12-21 大塚製藥股份有限公司 口服溶液
WO2016008393A1 (zh) * 2014-07-14 2016-01-21 正大天晴药业集团股份有限公司 头孢罗膦氨基酸盐及其结晶
CN104258403B (zh) * 2014-09-28 2017-03-01 刘宗侠 一种西洛他唑组合物及其制备方法
KR20170038214A (ko) * 2015-09-30 2017-04-07 (주)아모레퍼시픽 당산 및 플라보노이드를 포함하는 항균용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028355A (en) * 1974-01-23 1977-06-07 Smithkline Corporation Cephalosporin purification process
GB8729574D0 (en) * 1987-12-18 1988-02-03 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition
JP2761005B2 (ja) * 1988-11-02 1998-06-04 エーザイ株式会社 セファロスポリン含有注射用組成物
JPH02124822A (ja) * 1988-11-02 1990-05-14 Eisai Co Ltd セファロスポリン含有注射用組成物
DK0395219T3 (da) * 1989-03-30 1999-02-15 Pfizer Cephalosporiner og deres homologer, fremgangsmåde til deres fremstilling og farmaceutiske præparater
DE69004921T2 (de) * 1989-09-30 1994-05-05 Eisai Co Ltd Injizierbare Cephalosporinpräparate und ihre Anwendung.
JPH0840907A (ja) * 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
TW473479B (en) 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
US7527807B2 (en) * 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
JP3586226B2 (ja) * 2000-08-10 2004-11-10 武田薬品工業株式会社 ホスホノセフェム化合物
CA2418614C (en) * 2000-08-10 2008-06-10 Takeda Chemical Industries, Ltd. Phosphonocephem compound
TWI344847B (en) * 2003-04-28 2011-07-11 Takeda Chemical Industries Ltd Composition for injection

Also Published As

Publication number Publication date
US20150196572A1 (en) 2015-07-16
BRPI0816412A2 (pt) 2017-05-16
CN102935065A (zh) 2013-02-20
RU2010115268A (ru) 2011-10-27
AU2008302201A1 (en) 2009-03-26
RU2537237C2 (ru) 2014-12-27
CN101868240A (zh) 2010-10-20
EP2200618A1 (en) 2010-06-30
WO2009039324A1 (en) 2009-03-26
US20120010180A1 (en) 2012-01-12
KR20100075942A (ko) 2010-07-05
US20090082326A1 (en) 2009-03-26
CN103919720A (zh) 2014-07-16
CA2700263A1 (en) 2009-03-26
EP2200618A4 (en) 2010-11-03
JP2010540448A (ja) 2010-12-24
EP2952195A1 (en) 2015-12-09
KR101599560B1 (ko) 2016-03-03

Similar Documents

Publication Publication Date Title
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
IN2012DN01233A (enExample)
MX2009000884A (es) Derivados de piridizinona.
MY151986A (en) Adamantyl diamide derivatives and uses of same
MX363189B (es) Productos químicos, composiciones y métodos para tratamiento y prevención de infecciones de virus orthopox y enfermedades asociadas.
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
MX2014012695A (es) Derivados de isoindolona.
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
SG178952A1 (en) Chemical compounds
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
MY152018A (en) Indole derivatives as anticancer agents
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
EA201001858A1 (ru) Гетероциклические производные мочевины для лечения бактериальных инфекций
EA201001859A1 (ru) Гетероциклические производные мочевины и способы их применеия
TN2012000105A1 (en) Spirolactam derivatives and uses of same
MX2010003112A (es) Formas de dosificacion solubles que contienen derivados de cephem adecuados para administracion parenteral.
UA106200C2 (uk) Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину
TW200637817A (en) 5-aminoindole derivatives
TW200800993A (en) Organic compounds
IL191670A0 (en) Compounds for the inhibition of apoptosis
MX2009009074A (es) Macrolidos basados en eritromicina.
EP2124554A4 (en) COMPOSITIONS AND METHODS FOR CANCER TREATMENT
GEP20094745B (en) Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
MX337145B (es) Composiciones farmaceuticas.
WO2009124723A3 (en) Novel aureothin derivatives

Legal Events

Date Code Title Description
FG Grant or registration